We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USFD icon
1376
US Foods
USFD
$21.9B
$2.54M 0.01%
+73,141
New +$2.51M
FTEV.WS
1377
CALL
DELISTED
FinTech Evolution Acquisition Group Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
FTEV.WS
$2.52M 0.01%
260,616
MLAC
1378
DELISTED
Malacca Straits Acquisition Company Limited Class A Ordinary Shares
MLAC
$2.52M 0.01%
+253,962
New +$2.52M
AMRX icon
1379
Amneal Pharmaceuticals
AMRX
$5.78B
$2.52M 0.01%
472,137
-383,916
-45% -$1.93M
SYRE icon
1380
Spyre Therapeutics
SYRE
$8.69B
$2.51M 0.01%
12,633
-13,423
-52% -$2.35M
TOI icon
1381
The Oncology Institute
TOI
$519M
$2.5M 0.01%
252,439
+1,400
+0.6% +$13.9K
MXL icon
1382
MaxLinear
MXL
$5.88B
$2.5M 0.01%
+50,777
New +$2.46M
DLCAW
1383
CALL
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$2.5M 0.01%
256,697
+106,700
+71% +$85.6K
PYPL icon
1384
CALL
PayPal
PYPL
$49.5B
$2.5M 0.01%
9,600
+2,700
+39% +$766K
INOV
1385
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$2.5M 0.01%
+61,993
New +$2.34M
NVVEW
1386
CALL
DELISTED
Newborn Acquisition Corp Warrant
NVVEW
$2.48M 0.01%
230,000
DCRNW
1387
CALL
DELISTED
Decarbonization Plus Acquisition Corporation II Warrant
DCRNW
$2.48M 0.01%
250,953
HMCO
1388
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$2.48M 0.01%
250,810
+150,820
+151% +$1.47M
CAH icon
1389
Cardinal Health
CAH
$53.7B
$2.47M 0.01%
49,926
+34,803
+230% +$1.89M
SLAC
1390
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$2.46M 0.01%
252,085
+52,097
+26% +$505K
EUSGW
1391
CALL
DELISTED
European Sustainable Growth Acquisition Corp. Warrant
EUSGW
$2.46M 0.01%
248,484
+73,489
+42% +$83.5K
ABLLW
1392
CALL
DELISTED
Abacus Life Warrant
ABLLW
$2.46M 0.01%
250,307
SCI icon
1393
Service Corp International
SCI
$11.4B
$2.46M 0.01%
40,870
+1,785
+5% +$109K
FSSI
1394
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$2.46M 0.01%
252,034
SES icon
1395
SES AI
SES
$205M
$2.46M 0.01%
248,351
+123,365
+99% +$1.23M
TSIB
1396
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$2.46M 0.01%
+250,576
New +$2.45M
SHLX
1397
DELISTED
Shell Midstream Partners, L.P.
SHLX
$2.46M 0.01%
+208,587
New +$2.65M
TACA.WS
1398
CALL
DELISTED
Trepont Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordin
TACA.WS
$2.45M 0.01%
245,827
GHACW
1399
CALL
DELISTED
Gaming & Hospitality Acquisition Corp. Warrants
GHACW
$2.45M 0.01%
249,994
WOLF icon
1400
Wolfspeed
WOLF
$1.24B
$2.45M 0.01%
30,295
+16,084
+113% +$1.43M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.